Table of Contents
Chapter 1. Global Inactivated Vaccines Market Executive Summary
1.1. Global Inactivated Vaccines Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Vaccine Type
1.3.2. By Method of Inactivation
1.3.3. By Route of Administration
1.3.4. By End-User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Inactivated Vaccines Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Inactivated Vaccines Market Dynamics
3.1. Market Drivers
3.1.1. Rise in Incidence of Infectious Diseases
3.1.2. Increasing Number of Clinical Research Activities
3.2. Market Challenges
3.2.1. Stringent Regulatory Requirements
3.3. Market Opportunities
3.3.1. Technological Advancements in Vaccine Development
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Inactivated Vaccines Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Inactivated Vaccines Market Size & Forecasts by Vaccine Type 2022-2032
5.1. Segment Dashboard
5.2. Global Inactivated Vaccines Market: Vaccine Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Viral Vaccine
5.2.2. Bacterial Vaccine
Chapter 6. Global Inactivated Vaccines Market Size & Forecasts by Method of Inactivation 2022-2032
6.1. Segment Dashboard
6.2. Global Inactivated Vaccines Market: Method of Inactivation Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Solvent Detergent Method
6.2.2. Radiation Method
6.2.3. pH Concentration
6.2.4. Others
Chapter 7. Global Inactivated Vaccines Market Size & Forecasts by Route of Administration 2022-2032
7.1. Segment Dashboard
7.2. Global Inactivated Vaccines Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral
7.2.2. Subcutaneous
7.2.3. Intravenous
Chapter 8. Global Inactivated Vaccines Market Size & Forecasts by End-User 2022-2032
8.1. Segment Dashboard
8.2. Global Inactivated Vaccines Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Specialty Clinics
8.2.3. Homecare Settings
8.2.4. Others
Chapter 9. Global Inactivated Vaccines Market Size & Forecasts by Region 2022-2032
9.1. North America Inactivated Vaccines Market
9.1.1. U.S. Inactivated Vaccines Market
9.1.2. Canada Inactivated Vaccines Market
9.2. Europe Inactivated Vaccines Market
9.2.1. UK Inactivated Vaccines Market
9.2.2. Germany Inactivated Vaccines Market
9.2.3. France Inactivated Vaccines Market
9.2.4. Spain Inactivated Vaccines Market
9.2.5. Italy Inactivated Vaccines Market
9.2.6. Rest of Europe Inactivated Vaccines Market
9.3. Asia-Pacific Inactivated Vaccines Market
9.3.1. China Inactivated Vaccines Market
9.3.2. India Inactivated Vaccines Market
9.3.3. Japan Inactivated Vaccines Market
9.3.4. Australia Inactivated Vaccines Market
9.3.5. South Korea Inactivated Vaccines Market
9.3.6. Rest of Asia Pacific Inactivated Vaccines Market
9.4. Latin America Inactivated Vaccines Market
9.4.1. Brazil Inactivated Vaccines Market
9.4.2. Mexico Inactivated Vaccines Market
9.4.3. Rest of Latin America Inactivated Vaccines Market
9.5. Middle East & Africa Inactivated Vaccines Market
9.5.1. Saudi Arabia Inactivated Vaccines Market
9.5.2. South Africa Inactivated Vaccines Market
9.5.3. Rest of Middle East & Africa Inactivated Vaccines Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Mylan N.V.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Boehringer Ingelheim International GmbH
10.3.3. Merck & Co., Inc.
10.3.4. F. Hoffmann-La Roche AG
10.3.5. Bristol-Myers Squibb Company
10.3.6. Bharat Biotech
10.3.7. Serum Institute of India
10.3.8. GSK plc
10.3.9. Novartis AG
10.3.10. Sanofi S.A.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes